Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹2,098.70
Market cap: ₹2,327 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 51.0×Sector 50.4×
Promoter holding: 59.10%-5.53% QoQ
FII holding: 1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Management Change 1 Financial Results 1 Business Update 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 May 2026 15:14 IST NSE

Financial Results

Beta Drugs Q4 FY26 Results: Net Profit ₹90,489,234 Cr, Up 0.2% YoY

Beta Drugs Ltd reported revenue from operations of ₹939,649,419 Cr (+0.2% YoY) and net profit of ₹90,489,234 Cr (+0.2% YoY) for Q4 FY26.

Key figure: Net profit ₹90,489,234 Cr · +0.2% YoY

Open full results → Read the filing ↗